世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

細胞分離/細胞分別市場:製品毎(試薬、ビーズ、遠心分離機)、細胞タイプ毎(ヒト細胞、動物細胞)、細胞ソース毎(骨髄、脂肪)、技術毎(ろ過)、用途毎(がん)、エンドユーザ毎(病院、バイオテクノロジ) - 2024年までの世界市場予測

Cell Isolation/Cell Separation Market by Product (Reagents, Beads, Centrifuge), Cell Type (Human, Animal), Cell Source (Bone Marrow, Adipose), Technique (Filtration), Application (Cancer), End User (Hospitals, Biotechnology) - Global Forecast to 2024

 

出版社 出版年月電子版価格 ページ数図表数
MarketsandMarkets
マーケッツアンドマーケッツ
2019年2月US$5,650
シングルユーザライセンス
196 253

サマリー

幅広い市場に関する調査レポートを出版しているマーケッツアンドマーケッツ(MarketsandMarkets)の細胞分離/細胞分別市場に関する調査レポートです。

“The global cell isolation market is projected to register a CAGR of 17.2% during the forecast period.”

The market size for cell isolation is expected to reach USD 13.0 billion by 2024 from USD 5.9 billion in 2019, at a CAGR of 17.2%. The growth in this market is attributed to the increasing number of patients suffering from cancer and infectious diseases, increasing government funding for cell-based research, technological advancements, and the growing focus on personalized medicine.

“The bone marrow segment is estimated to grow rapidly during the forecast period.”

By cell source, the cell isolation market is segmented into three segments, namely, adipose tissue, bone marrow, and cord blood/embryonic stem cells. The bone marrow segment is projected to grow at the highest rate during the forecast period. This growth is attributed to the commercialization of a number of bone marrow-derived stem cell-based products for various therapeutic applications including aGVHD treatment, cardiovascular disease treatment, wound healing, tissue regeneration, and musculoskeletal disorders.

“The biomolecule isolation segment is estimated to grow rapidly during the forecast period.”

Based on application, the cell isolation market is segmented into biomolecule isolation, cancer research, stem cell research, tissue regeneration & regenerative medicine, and in vitro diagnostics. During the forecast period, the biomolecule isolation segment is estimated to register the highest growth rate in the overall cell isolation market.

This growth is mainly attributed to the increasing investments by companies for the production of biopharmaceutical products.

“Asia Pacific is estimated to register the highest CAGR during the forecast period.”

In this report, the cell isolation market is segmented into four major regional segments-North America, Europe, Asia Pacific, and the Rest of the World (RoW). The market in Asia Pacific is projected to register the highest growth rate during the forecast period. The growth in this market is primarily driven by the increasing incidence of chronic and infectious diseases and a growing population.

Breakdown of Profiles of Primary Participants:

- By Company Type: Tier 1-20%, Tier 2-45%, Tier 3-35%
- By Designation: C-level-30%, Director Level - 20%, Others - 50%
- By Region: North America-35%, Europe-24%, Asia-25%, Rest of the World - 16%

Key players in the cell isolation market include Beckman Coulter (US), Becton, Dickinson and Company (US), GE Healthcare (US), Merck KgaA (Germany), Miltenyi Biotec (Germany), pluriSelect (Germany), STEMCELL Technologies Inc. (Canada), Terumo BCT (US), Thermo Fisher Scientific (US), and Bio-Rad Laboratories Inc. (US).

Research Coverage:

The report analyzes the cell isolation market by product, cell type, cell source, technique, application, end user, and region. Apart from a comprehensive geographic product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by market players over the last three years. In addition, the company profiles include the product portfolios, developments, and strategies adopted by prominent market players to maintain and increase their shares in the market. Market research data, current market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output to remain successful in the market.

Key Benefits of Buying the Report:

This report will enable both established firms and new entrants/smaller firms to gauge the pulse of the market, which, in turn, will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below mentioned five strategies for strengthening their market shares.

The report provides insights on the following pointers:

- Market Penetration: Comprehensive information on the product portfolios of the top players in the cell isolation market
- Product Development/Innovation: Detailed insights on the product approvals, R&D activities, and product launches in the cell isolation market
- Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the cell isolation market
- Market Development: Detailed information about emerging markets. The report analyzes the market for various cell isolation across geographies
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the cell isolation market



目次

1 INTRODUCTION 21
1.1 OBJECTIVES OF THE STUDY 21
1.2 MARKET DEFINITION 21
1.2.1 MARKETS COVERED 22
1.2.2 COUNTRY COVERAGE 23
1.2.3 YEARS CONSIDERED FOR THE STUDY 23
1.3 CURRENCY 24
1.4 LIMITATIONS 24
1.5 STAKEHOLDERS 24

2 RESEARCH METHODOLOGY 25
2.1 SECONDARY DATA 26
2.1.1 KEY DATA FROM SECONDARY SOURCES 26
2.2 PRIMARY DATA 27
2.2.1 KEY DATA FROM PRIMARY SOURCES 28
2.3 MARKET SIZE ESTIMATION 29
2.3.1 BOTTOM-UP APPROACH 29
2.3.2 TOP-DOWN APPROACH 30
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 31
2.5 ASSUMPTIONS FOR THE STUDY 32

3 EXECUTIVE SUMMARY 33

4 PREMIUM INSIGHTS 39
4.1 CELL ISOLATION: MARKET OVERVIEW 39
4.2 NORTH AMERICA: CELL ISOLATION MARKET, BY PRODUCT (2018) 40
4.3 GEOGRAPHICAL SNAPSHOT OF THE CELL ISOLATION MARKET 41

5 MARKET OVERVIEW 42
5.1 INTRODUCTION 42
5.2 MARKET DYNAMICS 42
5.2.1 DRIVERS 43
5.2.1.1 Increasing government funding for cell-based research 43
5.2.1.2 Increasing number of patients suffering from cancer and infectious diseases 44
5.2.1.3 Technological advancements 45
5.2.1.4 Growing focus on personalized medicine 45
5.2.2 RESTRAINTS 46
5.2.2.1 Ethical issues related to embryonic stem cell isolation 46
5.2.2.2 High cost of cell-based research 46
5.2.3 OPPORTUNITIES 47
5.2.3.1 Emerging markets 47

6 CELL ISOLATION MARKET, BY PRODUCT 48
6.1 INTRODUCTION 49
6.2 CONSUMABLES 50
6.2.1 REAGENTS, KITS, MEDIA, AND SERA 51
6.2.1.1 Owing to the disposable nature of reagents and assay kits, this market is driven by their consistent usage and frequent purchases 51
6.2.2 BEADS 52
6.2.2.1 Growing demand for magnetic beads in T-cell and stem cell isolation is a major factor driving growth in this product segment 52
6.2.3 DISPOSABLES 52
6.2.3.1 Increasing investments in research by governments and companies are a major factor boosting the growth of the cell isolation disposables market 52
6.3 INSTRUMENTS 53
6.3.1 CENTRIFUGES 54
6.3.1.1 Growing use of centrifuges in the pharma-biotech industry and multi-functionality options offered by these instruments are driving the growth of this product segment 54
6.3.2 FLOW CYTOMETERS 55
6.3.2.1 Launch of innovative and cost-effective flow cytometers is likely to drive the growth of the market 55
6.3.3 MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS 56
6.3.4 FILTRATION SYSTEMS 56
6.3.4.1 Increasing research activities in cell biology to boost the market 56

7 CELL ISOLATION MARKET, BY CELL TYPE 58
7.1 INTRODUCTION 59
7.2 HUMAN CELLS 60
7.2.1 DIFFERENTIATED CELLS 61
7.2.1.1 Growing investments by market players to develop new and innovative products is expected to support the growth of the differentiated cell isolation market 61
7.2.2 STEM CELLS 62
7.2.2.1 Rising government initiatives focused on supporting stem cell research expected to drive market growth 62
7.3 ANIMAL CELLS 63
7.3.1 BIOPHARMACEUTICAL COMPANIES ARE THE MAJOR END USERS OF ISOLATED ANIMAL CELLS 63
-
8 CELL ISOLATION MARKET, BY CELL SOURCE 64
8.1 INTRODUCTION 65
8.2 BONE MARROW 66
8.2.1 A NUMBER OF BONE MARROW-DERIVED STEM CELLS HAVE BEEN COMMERCIALIZED IN THE LAST DECADE 66
8.3 ADIPOSE TISSUE 67
8.3.1 ADIPOSE STEM/STROMAL CELLS CAN GENERATE A VARIETY OF OTHER CELL TYPES 67
8.4 CORD BLOOD/EMBRYONIC STEM CELLS 68
8.4.1 MARKET GROWTH IS DRIVEN BY THE HIGH THERAPEUTIC POTENCY OF THESE STEM CELLS 68

9 CELL ISOLATION MARKET, BY TECHNIQUE 69
9.1 INTRODUCTION 70
9.2 CENTRIFUGATION-BASED CELL ISOLATION 71
9.2.1 COST-EFFECTIVENESS OF THIS TECHNIQUE IN BOTH SMALL-SCALE AND LARGE-SCALE OPERATIONS-A MAJOR DRIVER 71
9.3 SURFACE MARKER-BASED CELL ISOLATION 72
9.3.1 WIDE USAGE OF THIS TECHNIQUE IN BIOPHARMACEUTICAL AND BIOTECH INDUSTRIES IS A MAJOR REASON FOR THE GROWTH OF THIS MARKET 72
9.4 FILTRATION-BASED CELL ISOLATION 73
9.4.1 THE MAJOR FACTOR DRIVING THE GROWTH OF THIS MARKET SEGMENT IS THE LOW COST OF THE FILTRATION TECHNIQUE 73

10 CELL ISOLATION MARKET, BY APPLICATION 74
10.1 INTRODUCTION 75
10.2 BIOMOLECULE ISOLATION 76
10.2.1 BIOMOLECULE ISOLATION DOMINATES THE CELL ISOLATION APPLICATIONS MARKET 76
10.3 CANCER RESEARCH 77
10.3.1 HIGH DISEASE INCIDENCE HAS FUELLED THE DEMAND FOR ADVANCED TREATMENT 77
10.4 STEM CELL RESEARCH 78
10.4.1 INCREASING FUNDING IN STEM CELL RESEARCH TO SUPPORT MARKET GROWTH 78
10.5 TISSUE REGENERATION & REGENERATIVE MEDICINE 79
10.5.1 FUNDING FOR REGENERATIVE MEDICINE INITIATIVES HAS RISEN 79
10.6 IN VITRO DIAGNOSTICS 80
10.6.1 RISING DISEASE INCIDENCE HAS DRIVEN DEMAND FOR INNOVATIVE THERAPIES AND DIAGNOSTICS 80
-
11 CELL ISOLATION MARKET, BY END USER 81
11.1 INTRODUCTION 82
11.2 BIOTECHNOLOGY & BIOPHARMACEUTICAL COMPANIES 83
11.2.1 FAVORABLE INVESTMENTS HAVE BOOSTED OVERALL PACE OF RESEARCH 83
11.3 RESEARCH LABORATORIES & INSTITUTES 84
11.3.1 RISING FUNDING FOR CELL-BASED RESEARCH TO DRIVE MARKET GROWTH 84
11.4 HOSPITALS & DIAGNOSTIC LABORATORIES 85
11.4.1 INCREASING NUMBER OF HOSPITALS IN EMERGING COUNTRIES WILL CONTRIBUTE TO MARKET GROWTH 85
11.5 OTHER END USERS 86

12 CELL ISOLATION MARKET, BY REGION 87
12.1 INTRODUCTION 88
12.2 NORTH AMERICA 89
12.2.1 US 94
12.2.1.1 US to witness the highest growth in the North American cell isolation market due to the increasing government funding on cell-based research 94
12.2.2 CANADA 98
12.2.2.1 Increasing funding for research in regenerative medicine to support market growth in Canada 98
12.3 EUROPE 101
12.3.1 GERMANY 105
12.3.1.1 Germany to be fastest-growing market for cell isolation in Europe 105
12.3.2 FRANCE 109
12.3.2.1 Increasing prevalence of various chronic and infectious diseases to drive market growth 109
12.3.3 UK 113
12.3.3.1 Government investments in stem cell research to drive the market for cell isolation in the UK 113
12.3.4 ITALY 116
12.3.4.1 Increasing number of cell biology seminars and conferences to fuel the adoption of cell isolation products 116
12.3.5 SPAIN 120
12.3.5.1 Increasing funding from private and public organizations to aid market growth 120
12.3.6 REST OF EUROPE (ROE) 124
12.4 ASIA PACIFIC 128
12.4.1 JAPAN 132
12.4.1.1 Increasing geriatric population and substantial rise in the prevalence of chronic diseases will drive the market 132
12.4.2 CHINA 136
12.4.2.1 Cell therapy-based research is growing in China 136
12.4.3 INDIA 140
12.4.3.1 Rising incidence of chronic and infectious disease to drive demand for cell isolation products 140
12.4.4 REST OF ASIA PACIFIC 145
12.5 ROW 148
12.5.1 LATIN AMERICA 152
12.5.1.1 Rising incidence of chronic and infectious diseases will boost the market during the forecast period 152
12.5.2 MIDDLE EAST AND AFRICA 156
12.5.2.1 Increasing availability of funds will support the market  in the MEA 156

13 COMPETITIVE LANDSCAPE 160
13.1 OVERVIEW 160
13.2 MARKET RANKING ANALYSIS, 2017 161
13.3 KEY STRATEGIES 162
13.3.1 PRODUCT LAUNCHES, 2015-2018 162
13.3.2 EXPANSIONS, 2015-2018 162
13.3.3 PARTNERSHIPS, 2015-2018 162
13.3.4 ACQUISITIONS, 2015-2018 162
13.4 COMPETITIVE LEADERSHIP MAPPING (2017) 163
13.4.1 VANGUARDS 163
13.4.2 INNOVATORS 163
13.4.3 DYNAMIC PLAYERS 163
13.4.4 EMERGING PLAYERS 163
13.5 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS (2017) 165
13.5.1 PROGRESSIVE COMPANIES 165
13.5.2 STARTING BLOCKS 165
13.5.3 RESPONSIVE COMPANIES 165
13.5.4 DYNAMIC COMPANIES 165
-
14 COMPANY PROFILES 167
(Business Overview, Products Offered, Recent Developments, MnM View)*
14.1 THERMO FISHER SCIENTIFIC, INC. 167
14.2 BECTON, DICKINSON AND COMPANY 169
14.3 BECKMAN COULTER INC. (SUBSIDIARY OF DANAHER CORPORATION) 172
14.4 MERCK KGAA 174
14.5 TERUMO BCT (SUBSIDIARY OF TERUMO CORPORATION) 177
14.6 GE HEALTHCARE 179
14.7 BIO-RAD LABORATORIES, INC. 181
14.8 MILTENYI BIOTEC 183
14.9 PLURISELECT LIFE SCIENCE UG (HAFTUNGSBESCHR-NKT)  & CO. KG 185
14.10 STEMCELL TECHNOLOGIES, INC. 186
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

15 APPENDIX 187
15.1 INSIGHTS OF INDUSTRY EXPERTS 187
15.2 DISCUSSION GUIDE 188
15.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 192
15.4 AVAILABLE CUSTOMIZATIONS 194
15.5 RELATED REPORTS 194
15.1 AUTHOR DETAILS 195

 

LIST OF TABLES

TABLE 1 NIH FUNDING FOR CELL-BASED RESEARCH, 2014 VS. 2017 (USD MILLION) 43
TABLE 2 IMPORTANT STATISTICS ON INFECTIOUS DISEASES 45
TABLE 3 GROWTH IN THE NUMBER OF PERSONALIZED MEDICATIONS, 2008-2016 46
TABLE 4 CELL ISOLATION MARKET, BY PRODUCT, 2017-2024 (USD MILLION) 49
TABLE 5 CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION) 50
TABLE 6 CELL ISOLATION CONSUMABLES MARKET, BY REGION, 2017-2024 (USD MILLION) 51
TABLE 7 CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS, KITS, MEDIA, AND SERA, BY REGION, 2017-2024 (USD MILLION) 51
TABLE 8 CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY REGION,
2017-2024 (USD MILLION) 52
TABLE 9 CELL ISOLATION CONSUMABLES MARKET FOR DISPOSABLES, BY REGION,
2017-2024 (USD MILLION) 53
TABLE 10 CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION) 53
TABLE 11 CELL ISOLATION INSTRUMENTS MARKET, BY REGION, 2017-2024 (USD MILLION) 54
TABLE 12 CELL ISOLATION INSTRUMENTS MARKET FOR CENTRIFUGES, BY REGION,
2017-2024 (USD MILLION) 55
TABLE 13 CELL ISOLATION INSTRUMENTS MARKET FOR FLOW CYTOMETERS, BY REGION, 2017-2024 (USD MILLION) 55
TABLE 14 CELL ISOLATION INSTRUMENTS MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY REGION, 2017-2024 (USD MILLION) 56
TABLE 15 CELL ISOLATION INSTRUMENTS MARKET FOR FILTRATION SYSTEMS, BY REGION, 2017-2024(USD MILLION) 57
TABLE 16 CELL ISOLATION MARKET, BY CELL TYPE, 2017-2024 (USD MILLION) 59
TABLE 17 HUMAN CELL ISOLATION MARKET, BY CELL TYPE, 2017-2024 (USD MILLION) 60
TABLE 18 HUMAN CELL ISOLATION MARKET, BY REGION, 2017-2024 (USD MILLION) 60
TABLE 19 HUMAN DIFFERENTIATED CELL ISOLATION MARKET, BY REGION,
2017-2024 (USD MILLION) 61
TABLE 20 HUMAN STEM CELL ISOLATION MARKET, BY REGION, 2017-2024 (USD MILLION) 63
TABLE 21 ANIMAL CELL ISOLATION MARKET, BY REGION, 2017-2024 (USD MILLION) 63
TABLE 22 CELL ISOLATION MARKET, BY CELL SOURCE, 2017-2024 (USD MILLION) 65
TABLE 23 BONE MARROW CELL ISOLATION MARKET, BY REGION,
2017-2024 (USD MILLION) 66
TABLE 24 ADIPOSE TISSUE CELL ISOLATION MARKET, BY REGION,
2017-2024 (USD MILLION) 67
TABLE 25 CORD BLOOD/EMBRYONIC STEM CELL ISOLATION MARKET, BY REGION,
2017-2024 (USD MILLION) 68
TABLE 26 CELL ISOLATION MARKET, BY TECHNIQUE, 2017-2024 (USD MILLION) 70
TABLE 27 CENTRIFUGATION-BASED CELL ISOLATION MARKET, BY REGION,
2017-2024 (USD MILLION) 71
TABLE 28 SURFACE MARKER-BASED CELL ISOLATION MARKET , BY REGION,
2017-2024 (USD MILLION) 72
TABLE 29 FILTRATION-BASED CELL ISOLATION MARKET, BY REGION,
2017-2024 (USD MILLION) 73
TABLE 30 CELL ISOLATION MARKET, BY APPLICATION, 2017-2024 (USD MILLION) 75
TABLE 31 CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION, BY REGION,
2017-2024 (USD MILLION) 76
TABLE 32 CELL ISOLATION MARKET FOR CANCER RESEARCH, BY REGION,
2017-2024 (USD MILLION) 77
TABLE 33 CELL ISOLATION MARKET FOR STEM CELL RESEARCH, BY REGION,
2017-2024 (USD MILLION) 78
TABLE 34 CELL ISOLATION MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE, BY REGION, 2017-2024 (USD MILLION) 79
TABLE 35 CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTICS, BY REGION,
2017-2024 (USD MILLION) 80
TABLE 36 CELL ISOLATION MARKET, BY END USER, 2017-2021 (USD MILLION) 82
TABLE 37 CELL ISOLATION MARKET FOR BIOTECHNOLOGY & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2017-2024 (USD MILLION) 83
TABLE 38 CELL ISOLATION MARKET FOR RESEARCH LABORATORIES & INSTITUTES,
BY COUNTRY, 2017-2024 (USD MILLION) 84
TABLE 39 CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES,
BY COUNTRY, 2017-2024 (USD MILLION) 85
TABLE 40 CELL ISOLATION MARKET FOR OTHER END USERS, BY COUNTRY,
2017-2024 (USD MILLION) 86
TABLE 41 CELL ISOLATION MARKET, BY REGION, 2017-2024 (USD MILLION) 88
TABLE 42 NORTH AMERICA: CELL ISOLATION MARKET, BY COUNTRY,
2017-2024 (USD MILLION) 91
TABLE 43 NORTH AMERICA: CELL ISOLATION MARKET, BY PRODUCT,
2017-2024 (USD MILLION) 91
TABLE 44 NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE ,
2017-2024 (USD MILLION) 91
TABLE 45 NORTH AMERICA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE,
2017-2024 (USD MILLION) 92
TABLE 46 NORTH AMERICA: CELL ISOLATION MARKET, BY CELL TYPE,
2017-2024 (USD MILLION) 92
TABLE 47 NORTH AMERICA: HUMAN CELL ISOLATION MARKET, BY TYPE,
2017-2024 (USD MILLION) 92
TABLE 48 NORTH AMERICA: CELL ISOLATION MARKET, BY CELL SOURCE,
2017-2024 (USD MILLION) 93
TABLE 49 NORTH AMERICA: CELL ISOLATION MARKET, BY TECHNIQUE,
2017-2024 (USD MILLION) 93
TABLE 50 NORTH AMERICA: CELL ISOLATION MARKET, BY APPLICATION,
2017-2024 (USD MILLION) 93
TABLE 51 NORTH AMERICA: CELL ISOLATION MARKET, BY END USER,
2017-2024 (USD MILLION) 94
TABLE 52 US: CELL ISOLATION MARKET, BY PRODUCT, 2017-2024 (USD MILLION) 95
TABLE 53 US: CELL ISOLATION CONSUMABLES MARKET, BY TYPE ,
2017-2024 (USD MILLION) 95
TABLE 54 US: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE,
2017-2024 (USD MILLION) 95
TABLE 55 US: CELL ISOLATION MARKET, BY CELL TYPE, 2017-2024 (USD MILLION) 96
TABLE 56 US: HUMAN CELL ISOLATION MARKET, BY TYPE, 2017-2024 (USD MILLION) 96
TABLE 57 US: CELL ISOLATION MARKET, BY CELL SOURCE, 2017-2024 (USD MILLION) 96
TABLE 58 US: CELL ISOLATION MARKET, BY TECHNIQUE, 2017-2024 (USD MILLION) 97
TABLE 59 US: CELL ISOLATION MARKET, BY APPLICATION, 2017-2024 (USD MILLION) 97
TABLE 60 US: CELL ISOLATION MARKET, BY END USER, 2017-2024 (USD MILLION) 97
TABLE 61 CANADA: CELL ISOLATION MARKET, BY PRODUCT, 2017-2024 (USD MILLION) 98
TABLE 62 CANADA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE,
2017-2024 (USD MILLION) 99
TABLE 63 CANADA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE,
2017-2024 (USD MILLION) 99
TABLE 64 CANADA: CELL ISOLATION MARKET, BY CELL TYPE, 2017-2024 (USD MILLION) 99
TABLE 65 CANADA: HUMAN CELL ISOLATION MARKET, BY TYPE, 2017-2024 (USD MILLION) 100
TABLE 66 CANADA: CELL ISOLATION MARKET, BY CELL SOURCE, 2017-2024 (USD MILLION) 100
TABLE 67 CANADA: CELL ISOLATION MARKET, BY TECHNIQUE, 2017-2024 (USD MILLION) 100
TABLE 68 CANADA: CELL ISOLATION MARKET, BY APPLICATION, 2017-2024 (USD MILLION) 101
TABLE 69 CANADA: CELL ISOLATION MARKET, BY END USER, 2017-2024 (USD MILLION) 101
TABLE 70 EUROPE: CELL ISOLATION MARKET, BY COUNTRY, 2017-2024 (USD MILLION) 102
TABLE 71 EUROPE: CELL ISOLATION MARKET, BY PRODUCT, 2017-2024 (USD MILLION) 102
TABLE 72 EUROPE: CELL ISOLATION CONSUMABLES MARKET, BY TYPE ,
2017-2024 (USD MILLION) 102
TABLE 73 EUROPE: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE,
2017-2024 (USD MILLION) 103
TABLE 74 EUROPE: CELL ISOLATION MARKET, BY CELL TYPE, 2017-2024 (USD MILLION) 103
TABLE 75 EUROPE: HUMAN CELL ISOLATION MARKET, BY TYPE, 2017-2024 (USD MILLION) 103
TABLE 76 EUROPE: CELL ISOLATION MARKET, BY CELL SOURCE, 2017-2024 (USD MILLION) 104
TABLE 77 EUROPE: CELL ISOLATION MARKET, BY TECHNIQUE, 2017-2024 (USD MILLION) 104
TABLE 78 EUROPE: CELL ISOLATION MARKET, BY APPLICATION, 2017-2024 (USD MILLION) 104
TABLE 79 EUROPE: CELL ISOLATION MARKET, BY END USER, 2017-2024 (USD MILLION) 105
TABLE 80 GERMANY: CELL ISOLATION MARKET, BY PRODUCT, 2017-2024 (USD MILLION) 105
TABLE 81 GERMANY: CELL ISOLATION CONSUMABLES MARKET, BY TYPE ,
2017-2024 (USD MILLION) 106
TABLE 82 GERMANY: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE,
2017-2024 (USD MILLION) 106
TABLE 83 GERMANY: CELL ISOLATION MARKET, BY CELL TYPE, 2017-2024 (USD MILLION) 106
TABLE 84 GERMANY: HUMAN CELL ISOLATION MARKET, BY TYPE,
2017-2024 (USD MILLION) 107
TABLE 85 GERMANY: CELL ISOLATION MARKET, BY CELL SOURCE,
2017-2024 (USD MILLION) 107
TABLE 86 GERMANY: CELL ISOLATION MARKET, BY TECHNIQUE, 2017-2024 (USD MILLION) 107
TABLE 87 GERMANY: CELL ISOLATION MARKET, BY APPLICATION,
2017-2024 (USD MILLION) 108
TABLE 88 GERMANY: CELL ISOLATION MARKET, BY END USER, 2017-2024 (USD MILLION) 108
TABLE 89 FRANCE: CELL ISOLATION MARKET, BY PRODUCT, 2017-2024 (USD MILLION) 110
TABLE 90 FRANCE: CELL ISOLATION CONSUMABLES MARKET, BY TYPE ,
2017-2024 (USD MILLION) 110
TABLE 91 FRANCE: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE,
2017-2024 (USD MILLION) 110
TABLE 92 FRANCE: CELL ISOLATION MARKET, BY CELL TYPE, 2017-2024 (USD MILLION) 111
TABLE 93 FRANCE: HUMAN CELL ISOLATION MARKET, BY TYPE, 2017-2024 (USD MILLION) 111
TABLE 94 FRANCE: CELL ISOLATION MARKET, BY CELL SOURCE, 2017-2024 (USD MILLION) 111
TABLE 95 FRANCE: CELL ISOLATION MARKET, BY TECHNIQUE, 2017-2024 (USD MILLION) 112
TABLE 96 FRANCE: CELL ISOLATION MARKET, BY APPLICATION, 2017-2024 (USD MILLION) 112
TABLE 97 FRANCE: CELL ISOLATION MARKET, BY END USER, 2017-2024 (USD MILLION) 112
TABLE 98 UK: CELL ISOLATION MARKET, BY PRODUCT, 2017-2024 (USD MILLION) 113
TABLE 99 UK: CELL ISOLATION CONSUMABLES MARKET, BY TYPE ,
2017-2024 (USD MILLION) 114
TABLE 100 UK: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE,
2017-2024 (USD MILLION) 114
TABLE 101 UK: CELL ISOLATION MARKET, BY CELL TYPE, 2017-2024 (USD MILLION) 114
TABLE 102 UK: HUMAN CELL ISOLATION MARKET, BY TYPE, 2017-2024 (USD MILLION) 115
TABLE 103 UK: CELL ISOLATION MARKET, BY CELL SOURCE, 2017-2024 (USD MILLION) 115
TABLE 104 UK: CELL ISOLATION MARKET, BY TECHNIQUE, 2017-2024 (USD MILLION) 115
TABLE 105 UK: CELL ISOLATION MARKET, BY APPLICATION, 2017-2024 (USD MILLION) 116
TABLE 106 UK: CELL ISOLATION MARKET, BY END USER, 2017-2024 (USD MILLION) 116
TABLE 107 ITALY: CELL ISOLATION MARKET, BY PRODUCT, 2017-2024 (USD MILLION) 117
TABLE 108 ITALY: CELL ISOLATION CONSUMABLES MARKET, BY TYPE ,
2017-2024 (USD MILLION) 117
TABLE 109 ITALY: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE,
2017-2024 (USD MILLION) 118
TABLE 110 ITALY: CELL ISOLATION MARKET, BY CELL TYPE, 2017-2024 (USD MILLION) 118
TABLE 111 ITALY: HUMAN CELL ISOLATION MARKET, BY TYPE, 2017-2024 (USD MILLION) 118
TABLE 112 ITALY: CELL ISOLATION MARKET, BY CELL SOURCE, 2017-2024 (USD MILLION) 119
TABLE 113 ITALY: CELL ISOLATION MARKET, BY TECHNIQUE, 2017-2024 (USD MILLION) 119
TABLE 114 ITALY: CELL ISOLATION MARKET, BY APPLICATION, 2017-2024 (USD MILLION) 119
TABLE 115 ITALY: CELL ISOLATION MARKET, BY END USER, 2017-2024 (USD MILLION) 120
TABLE 116 SPAIN: CELL ISOLATION MARKET, BY PRODUCT, 2017-2024 (USD MILLION) 121
TABLE 117 SPAIN: CELL ISOLATION CONSUMABLES MARKET, BY TYPE ,
2017-2024 (USD MILLION) 121
TABLE 118 SPAIN: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE,
2017-2024 (USD MILLION) 122
TABLE 119 SPAIN: CELL ISOLATION MARKET, BY CELL TYPE, 2017-2024 (USD MILLION) 122
TABLE 120 SPAIN: HUMAN CELL ISOLATION MARKET, BY TYPE, 2017-2024 (USD MILLION) 122
TABLE 121 SPAIN: CELL ISOLATION MARKET, BY CELL SOURCE, 2017-2024 (USD MILLION) 123
TABLE 122 SPAIN: CELL ISOLATION MARKET, BY TECHNIQUE, 2017-2024 (USD MILLION) 123
TABLE 123 SPAIN: CELL ISOLATION MARKET, BY APPLICATION, 2017-2024 (USD MILLION) 123
TABLE 124 SPAIN: CELL ISOLATION MARKET, BY END USER, 2017-2024 (USD MILLION) 124
TABLE 125 ROE: CELL ISOLATION MARKET, BY PRODUCT, 2017-2024 (USD MILLION) 124
TABLE 126 ROE: CELL ISOLATION CONSUMABLES MARKET, BY TYPE ,
2017-2024 (USD MILLION) 125
TABLE 127 ROE: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE,
2017-2024 (USD MILLION) 125
TABLE 128 ROE: CELL ISOLATION MARKET, BY CELL TYPE, 2017-2024 (USD MILLION) 125
TABLE 129 ROE: HUMAN CELL ISOLATION MARKET, BY TYPE, 2017-2024 (USD MILLION) 126
TABLE 130 ROE: CELL ISOLATION MARKET, BY CELL SOURCE, 2017-2024 (USD MILLION) 126
TABLE 131 ROE: CELL ISOLATION MARKET, BY TECHNIQUE, 2017-2024 (USD MILLION) 126
TABLE 132 ROE: CELL ISOLATION MARKET, BY APPLICATION, 2017-2024 (USD MILLION) 127
TABLE 133 ROE: CELL ISOLATION MARKET, BY END USER, 2017-2024 (USD MILLION) 127
TABLE 134 ASIA PACIFIC: CELL ISOLATION MARKET, BY COUNTRY, 2017-2024 (USD MILLION) 129
TABLE 135 ASIA PACIFIC: CELL ISOLATION MARKET, BY PRODUCT, 2017-2024 (USD MILLION) 129
TABLE 136 ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET, BY TYPE,
2017-2024 (USD MILLION) 129
TABLE 137 ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE,
2017-2024 (USD MILLION) 130
TABLE 138 ASIA PACIFIC: CELL ISOLATION MARKET, BY CELL TYPE,
2017-2024 (USD MILLION) 130
TABLE 139 ASIA PACIFIC: HUMAN CELL ISOLATION MARKET, BY TYPE,
2017-2024 (USD MILLION) 130
TABLE 140 ASIA PACIFIC: CELL ISOLATION MARKET, BY CELL SOURCE,
2017-2024 (USD MILLION) 131
TABLE 141 ASIA PACIFIC: CELL ISOLATION MARKET, BY TECHNIQUE,
2017-2024 (USD MILLION) 131
TABLE 142 ASIA PACIFIC: CELL ISOLATION MARKET, BY APPLICATION,
2017-2024 (USD MILLION) 131
TABLE 143 ASIA PACIFIC: CELL ISOLATION MARKET, BY END USER,
2017-2024 (USD MILLION) 132
TABLE 144 JAPAN: CELL ISOLATION MARKET, BY PRODUCT, 2017-2024 (USD MILLION) 133
TABLE 145 JAPAN: CELL ISOLATION CONSUMABLES MARKET, BY TYPE,
2017-2024 (USD MILLION) 133
TABLE 146 JAPAN: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE,
2017-2024 (USD MILLION) 133
TABLE 147 JAPAN: CELL ISOLATION MARKET, BY CELL TYPE, 2017-2024 (USD MILLION) 134
TABLE 148 JAPAN: HUMAN CELL ISOLATION MARKET, BY TYPE, 2017-2024 (USD MILLION) 134
TABLE 149 JAPAN: CELL ISOLATION MARKET, BY CELL SOURCE, 2017-2024 (USD MILLION) 134
TABLE 150 JAPAN: CELL ISOLATION MARKET, BY TECHNIQUE, 2017-2024 (USD MILLION) 135
TABLE 151 JAPAN: CELL ISOLATION MARKET, BY APPLICATION, 2017-2024 (USD MILLION) 135
TABLE 152 JAPAN: CELL ISOLATION MARKET, BY END USER, 2017-2024 (USD MILLION) 135
TABLE 153 CHINA: CELL ISOLATION MARKET, BY PRODUCT, 2017-2024 (USD MILLION) 137
TABLE 154 CHINA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE,
2017-2024 (USD MILLION) 137
TABLE 155 CHINA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE,
2017-2024 (USD MILLION) 137
TABLE 156 CHINA: CELL ISOLATION MARKET, BY CELL TYPE, 2017-2024 (USD MILLION) 138
TABLE 157 CHINA: HUMAN CELL ISOLATION MARKET, BY TYPE, 2017-2024 (USD MILLION) 138
TABLE 158 CHINA: CELL ISOLATION MARKET, BY CELL SOURCE, 2017-2024 (USD MILLION) 138
TABLE 159 CHINA: CELL ISOLATION MARKET, BY TECHNIQUE, 2017-2024 (USD MILLION) 139
TABLE 160 CHINA: CELL ISOLATION MARKET, BY APPLICATION, 2017-2024 (USD MILLION) 139
TABLE 161 CHINA: CELL ISOLATION MARKET, BY END USER, 2017-2024 (USD MILLION) 140
TABLE 162 INDIA: CELL ISOLATION MARKET, BY PRODUCT, 2017-2024 (USD MILLION) 141
TABLE 163 INDIA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE,
2017-2024 (USD MILLION) 142
TABLE 164 INDIA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE,
2017-2024 (USD MILLION) 142
TABLE 165 INDIA: CELL ISOLATION MARKET, BY CELL TYPE, 2017-2024 (USD MILLION) 142
TABLE 166 INDIA: HUMAN CELL ISOLATION MARKET, BY TYPE, 2017-2024 (USD MILLION) 143
TABLE 167 INDIA: CELL ISOLATION MARKET, BY CELL SOURCE, 2017-2024 (USD MILLION) 143
TABLE 168 INDIA: CELL ISOLATION MARKET, BY TECHNIQUE, 2017-2024 (USD MILLION) 143
TABLE 169 INDIA: CELL ISOLATION MARKET, BY APPLICATION, 2017-2024 (USD MILLION) 144
TABLE 170 INDIA: CELL ISOLATION MARKET, BY END USER, 2017-2024 (USD MILLION) 144
TABLE 171 ROAPAC: CELL ISOLATION MARKET, BY PRODUCT, 2017-2024 (USD MILLION) 145
TABLE 172 ROAPAC: CELL ISOLATION CONSUMABLES MARKET, BY TYPE,
2017-2024 (USD MILLION) 146
TABLE 173 ROAPAC: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE,
2017-2024 (USD MILLION) 146
TABLE 174 ROAPAC: CELL ISOLATION MARKET, BY CELL TYPE, 2017-2024 (USD MILLION) 146
TABLE 175 ROAPAC: HUMAN CELL ISOLATION MARKET, BY TYPE, 2017-2024 (USD MILLION) 147
TABLE 176 ROAPAC: CELL ISOLATION MARKET, BY CELL SOURCE, 2017-2024 (USD MILLION) 147
TABLE 177 ROAPAC: CELL ISOLATION MARKET, BY TECHNIQUE, 2017-2024 (USD MILLION) 147
TABLE 178 ROAPAC: CELL ISOLATION MARKET, BY APPLICATION, 2017-2024 (USD MILLION) 148
TABLE 179 ROAPAC: CELL ISOLATION MARKET, BY END USER, 2017-2024 (USD MILLION) 148
TABLE 180 ROW: CELL ISOLATION MARKET, BY REGION, 2017-2024 (USD MILLION) 149
TABLE 181 ROW: CELL ISOLATION MARKET, BY PRODUCT, 2017-2024 (USD MILLION) 149
TABLE 182 ROW: CELL ISOLATION CONSUMABLES MARKET, BY TYPE,
2017-2024 (USD MILLION) 149
TABLE 183 ROW: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE,
2017-2024 (USD MILLION) 150
TABLE 184 ROW: CELL ISOLATION MARKET, BY CELL TYPE, 2017-2024 (USD MILLION) 150
TABLE 185 ROW: HUMAN CELL ISOLATION MARKET, BY TYPE, 2017-2024 (USD MILLION) 150
TABLE 186 ROW: CELL ISOLATION MARKET, BY CELL SOURCE, 2017-2024 (USD MILLION) 151
TABLE 187 ROW: CELL ISOLATION MARKET, BY TECHNIQUE, 2017-2024 (USD MILLION) 151
TABLE 188 ROW: CELL ISOLATION MARKET, BY APPLICATION, 2017-2024 (USD MILLION) 151
TABLE 189 ROW: CELL ISOLATION MARKET, BY END USER, 2017-2024 (USD MILLION) 152
TABLE 190 LATIN AMERICA: CELL ISOLATION MARKET, BY PRODUCT,
2017-2024 (USD MILLION) 153
TABLE 191 LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE,
2017-2024 (USD MILLION) 153
TABLE 192 LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE,
2017-2024 (USD MILLION) 153
TABLE 193 LATIN AMERICA: CELL ISOLATION MARKET, BY CELL TYPE,
2017-2024 (USD MILLION) 154
TABLE 194 LATIN AMERICA: HUMAN CELL ISOLATION MARKET, BY TYPE,
2017-2024 (USD MILLION) 154
TABLE 195 LATIN AMERICA: CELL ISOLATION MARKET, BY CELL SOURCE,
2017-2024 (USD MILLION) 154
TABLE 196 LATIN AMERICA: CELL ISOLATION MARKET, BY TECHNIQUE,
2017-2024 (USD MILLION) 155
TABLE 197 LATIN AMERICA: CELL ISOLATION MARKET, BY APPLICATION,
2017-2024 (USD MILLION) 155
TABLE 198 LATIN AMERICA: CELL ISOLATION MARKET, BY END USER,
2017-2024 (USD MILLION) 155
TABLE 199 MIDDLE EAST AND AFRICA: CELL ISOLATION MARKET, BY PRODUCT,
2017-2024 (USD MILLION) 156
TABLE 200 MIDDLE EAST AND AFRICA: CELL ISOLATION CONSUMABLES MARKET,
BY TYPE, 2017-2024 (USD MILLION) 156
TABLE 201 MIDDLE EAST AND AFRICA: CELL ISOLATION INSTRUMENTS MARKET,
BY TYPE, 2017-2024 (USD MILLION) 157
TABLE 202 MIDDLE EAST AND AFRICA: CELL ISOLATION MARKET, BY CELL TYPE,
2017-2024 (USD MILLION) 157
TABLE 203 MIDDLE EAST AND AFRICA: HUMAN CELL ISOLATION MARKET, BY TYPE,
2017-2024 (USD MILLION) 158
TABLE 204 MIDDLE EAST AND AFRICA: CELL ISOLATION MARKET, BY CELL SOURCE,
2017-2024 (USD MILLION) 158
TABLE 205 MIDDLE EAST AND AFRICA: CELL ISOLATION MARKET, BY TECHNIQUE,
2017-2024 (USD MILLION) 158
TABLE 206 MIDDLE EAST AND AFRICA: CELL ISOLATION MARKET, BY APPLICATION,
2017-2024 (USD MILLION) 159
TABLE 207 MIDDLE EAST AND AFRICA: CELL ISOLATION MARKET, BY END USER,
2017-2024 (USD MILLION) 159
TABLE 208 TOP FIVE COMPANIES IN THE CELL ISOLATION MARKET, 2017 161

 

LIST OF FIGURES

FIGURE 1 GLOBAL CELL ISOLATION MARKET 22
FIGURE 2 GLOBAL CELL ISOLATION MARKET COUNTRY COVERAGE 23
FIGURE 3 GLOBAL CELL ISOLATION MARKET YEARS CONSIDERED FOR THE STUDY 23
FIGURE 4 RESEARCH DESIGN 25
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,  AND REGION 27
FIGURE 6 CELL ISOLATION MARKET: BOTTOM-UP APPROACH 29
FIGURE 7 CELL ISOLATION MARKET: TOP-DOWN APPROACH 30
FIGURE 8 DATA TRIANGULATION METHODOLOGY 31
FIGURE 9 CELL ISOLATION MARKET, BY PRODUCT, 2019 VS. 2024 (USD BILLION) 33
FIGURE 10 CELL ISOLATION MARKET, BY CELL TYPE, 2019 VS. 2024 (USD BILLION) 34
FIGURE 11 CELL ISOLATION MARKET, BY CELL SOURCE, 2019 VS. 2024 (USD BILLION) 35
FIGURE 12 CELL ISOLATION MARKET, BY TECHNIQUE, 2019 VS. 2024 (USD BILLION) 35
FIGURE 13 CELL ISOLATION MARKET, BY APPLICATION, 2019 VS. 2024 (USD BILLION) 36
FIGURE 14 CELL ISOLATION MARKET, BY END USER, 2019 VS. 2024 (USD BILLION) 37
FIGURE 15 CELL ISOLATION MARKET, BY REGION, 2019 VS. 2024 (USD BILLION) 37
FIGURE 16 INCREASING FUNDING FOR CELL-BASED RESEARCH TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD 39
FIGURE 17 CONSUMABLES DOMINATED THE NORTH AMERICAN CELL ISOLATION MARKET
IN 2018 40
FIGURE 18 COUNTRIES IN ASIA PACIFIC TO REGISTER A HIGHER GROWTH RATE DURING THE FORECAST PERIOD 41
FIGURE 19 CELL ISOLATION MARKET: DRIVERS, RESTRAINTS, & OPPORTUNITIES 42
FIGURE 20 INCIDENCE OF CANCER, BY REGION, 2012-2035 (MILLION) 44
FIGURE 21 CONSUMABLES TO DOMINATE THE CELL ISOLATION PRODUCTS MARKET DURING THE FORECAST PERIOD 49
FIGURE 22 HUMAN CELLS SEGMENT TO DOMINATE THE MARKET DURING  THE FORECAST PERIOD 59
FIGURE 23 BONE MARROW SEGMENT TO DOMINATE THE CELL ISOLATION MARKET DURING FORECAST PERIOD 65
FIGURE 24 CENTRIFUGATION-BASED CELL ISOLATION TO DOMINATE THE MARKET IN 2019 70
FIGURE 25 BIOMOLECULE ISOLATION SEGMENT TO DOMINATE THE CELL ISOLATION MARKET DURING THE FORECAST PERIOD 75
FIGURE 26 BIOTECHNOLOGY & BIOPHARMACEUTICAL COMPANIES TO DOMINATE THE END-USER MARKET FOR CELL ISOLATION 82
FIGURE 27 NORTH AMERICA WILL CONTINUE TO DOMINATE THE CELL ISOLATION 
MARKET IN 2024 88
FIGURE 28 NORTH AMERICA: CELL ISOLATION MARKET SNAPSHOT 90
FIGURE 29 INCIDENCE OF CANCER IN FRANCE 109
FIGURE 30 INCIDENCE OF CANCER IN SPAIN 120
FIGURE 31 ASIA PACIFIC: CELL ISOLATION MARKET SNAPSHOT 128
FIGURE 32 PROJECTED RISE IN CANCER INCIDENCE IN JAPAN 132
FIGURE 33 INCIDENCE OF CANCER IN CHINA 136
FIGURE 34 INCIDENCE OF CANCER IN INDIA 141
FIGURE 35 NUMBER OF NEW HIV INFECTIONS DIAGNOSED IN LATIN AMERICAN COUNTRIES 152
FIGURE 36 KEY DEVELOPMENTS IN THE CELL ISOLATION MARKET FROM 2015 TO 2018 160
FIGURE 37 MNM DIVE-VENDOR COMPARISON MATRIX: CELL ISOLATION MARKET 164
FIGURE 38 MNM DIVE-VENDOR COMPARISON MATRIX FOR START-UPS: CELL ISOLATION MARKET 166
FIGURE 39 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2017) 167
FIGURE 40 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2018) 169
FIGURE 41 DANAHER CORPORATION: COMPANY SNAPSHOT (2017) 172
FIGURE 42 MERCK KGAA: COMPANY SNAPSHOT (2017) 174
FIGURE 43 TERUMO CORPORATION: COMPANY SNAPSHOT (2017) 177
FIGURE 44 GE HEALTHCARE: COMPANY SNAPSHOT (2017) 179
FIGURE 45 BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2017) 181

 

ページTOPに戻る

あなたが最近チェックしたレポート一覧

  • 最近チェックしたレポートはありません。

お問合は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのお問合せはこちらのフォームから承ります

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

<無料>メルマガに登録する

 

 

ページTOPに戻る